seed
Stage
2026
Founded
2
Investors
About
VivArt-X develops synthetic, degradable biomaterials for personalized breast reconstruction in women who have undergone breast tissue removal due to cancer, supporting cell engraftment and regeneration.
Explore VivArt-X B.V's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.